跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,127 条关于
“Assenagon Asset Management S.A.”
全部
28,127
临床试验
17,728
药物
447
机构
719
资讯
9,233
上个月
Seth Klarman's Baupost Group Fully Exits Vaxcyte Ahead of Pivotal VAX-31 Phase 3 Readout
去年
Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment
去年
Oncodesign Precision Medicine Presents Positive Phase 1 Data for RIPK2 Inhibitor OPM-101 in Healthy Volunteers
去年
Norstella Launches NorstellaLinQ, an Integrated Data Asset for Biopharma
6年前
FTC Clears AbbVie's $63 Billion Allergan Acquisition with Asset Divestiture Requirements
9个月前
Apimeds Pharmaceuticals Merges with AI-Driven Digital Asset Company MindWave in $100M Deal
去年
WuXi Companies Consider Asset Sales Amid US BIOSECURE Act Pressure
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
去年
Siren Biotechnology's SRN-101 Receives FDA Designations for High-Grade Gliomas
去年
Pharmaceutical Asset Purchase Deals Show Sustained Growth Since 2019, Report Reveals
第 1 页，共 924 页
上一页
下一页
